Barriers to Prescribing Buprenorphine in the Emergency Department.  Kim HS, Samuels EA. Overcoming  JAMA Netw Open. 2020;3(5):e204996. doi:10.1001/jamanetworkopen.2020.4996 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/27…

USA. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Full Document. This updated Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to…

CLINICAL GUIDELINES FOR USE OF DEPOT BUPRENORPHINE (BUVIDAL®) IN THE TREATMENT OF OPIOID DEPENDENCE This Clinical Guideline has been developed to inform decision-making by clinicians prescribing and/or patients being treated with Buvidal® long…

EMA. Summary of opinion (post authorisation): Suboxone (buprenorphine / naloxone) sublingual film On 30 April 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marke…

Two world first studies of depot buprenorphine completed Two world first studies of depot buprenorphine have recently been completed. Both studies are great achievements at the forefront of international research efforts in this field and have sali…

Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder. Melnick ER, Nath B, Ahmed OM, Brandt C, Chartash D, Dziura JD, Hess EP, Hollan…